The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy
Conditions: Mastectomy; Lymphedema; Breast Cancer Intervention: Other: Supportive care and education before surgery Sponsor: Saglik Bilimleri Universitesi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS
Condition: DCIS Intervention: Procedure: Delay sentinel node biopsy Sponsor: Seoul National University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy
Conditions: Mastectomy; Lymphedema; Breast Cancer Intervention: Other: Supportive care and education before surgery Sponsor: Saglik Bilimleri Universitesi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS
Condition: DCIS Intervention: Procedure: Delay sentinel node biopsy Sponsor: Seoul National University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
The Effect of Preoperative Education on Postoperative Healing Quality in Patients With Mastectomy
Conditions: Mastectomy; Lymphedema; Breast Cancer Intervention: Other: Supportive care and education before surgery Sponsor: Saglik Bilimleri Universitesi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
Conditions: Breast Cancer; DCIS; Invasive Duct Carcinoma of Breast Interventions: Drug: LS301-IT 0.025 mg/kg; Drug: LS301-IT 0.05 mg/kg; Drug: LS301-IT 0.075 mg/kg; Drug: LS301-IT 0.1 mg/kg Sponsor: Integro Theranostics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2023 Category: Research Source Type: clinical trials